Low-density lipoprotein cholesterol in high-risk asymptomatic individuals.

about

Low-density lipoprotein cholesterol in high-risk asymptomatic individuals.

Item

http://www.wikidata.org/entity/Q36904436

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Low-density lipoprotein cholesterol in high-risk asymptomatic individuals.

@en

type

Item

label

Low-density lipoprotein cholesterol in high-risk asymptomatic individuals.

@en

prefLabel

Low-density lipoprotein cholesterol in high-risk asymptomatic individuals.

@en

P1476

Low-density lipoprotein cholesterol in high-risk asymptomatic individuals.

@en

P2093

Dominique Ashen

http://www.w3.org/2001/XMLSchema#string

Juan J Rivera

http://www.w3.org/2001/XMLSchema#string

Roger S Blumenthal

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.

Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

P304

49-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1559-4564.2007.06108.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6155973

http://www.w3.org/2001/XMLSchema#string

P698

17684449

http://www.w3.org/2001/XMLSchema#string

P921

LDL cholesterol